Head Finance Generic Platform; d​/f​/m

See Job Description.

Sandoz continues to go through an exciting and transformative period as a global leader and pioneering provider of sustainable Biosimilar and Generic medicines. As we continue down this new and ambitious path, unique opportunities will present themselves, both professionally and personally. Join us, the future is ours to shape!

The Head Finance Generic Platform is the financial leader driving value creation across the Standard and Specialty Generics value chain. The role will pro-actively drive optimal resource allocation, prioritising investments with key focus on oral solids, injectables and respiratory across internal development, BD&L and life cycle mgt. Coordinates together with STO, Regions and Countries short-, medium- and long-term projections and designs and implement improvement measures supporting a margin expansion roadmap.

This role has the responsibility to support decision making of pipeline choices ensuring financial alignment with companies' expectations, as well, as facilitating successful pre and launch activities. Success requires financial leadership, advanced financial modelling, and deep analytical insight into portfolio, pipeline, and market dynamics, while ensuring strong collaboration and alignment with commercial regions and manufacturing priorities.

Your responsibilities include, but are not limited to:

Co-creates overall Generics strategy and ad-hoc activities to deliver competitive, sustainable growth for Sandoz. Decision member in related Standard and Specialty Generics decision/operating bodies in relation to strategy, portfolio, pipeline, LCM and BD&L.

Develops and delivers business cases: maximizing ROI for selection of new molecule additions, BD&L investment decisions and monitoring of existing portfolio and making recommendation decisions on investment choices.

Partners with CCO, Development, and Manufacturing leadership to drive comprehensive, end-to-end business cases securing approvals under governance frameworks.

Finance Business Partner in the BD&L investment choices. Ensure compliance with financial commitments of existing partnerships and leads term improvements ensuring profitability levels.

Provides transparency of financial implications of the 3 year regional demand planning (APO). Drives optimal/ lean resource allocation across Commercial Regions to maximize sales and profit to the Commercial Heads and CFO. Ensuring best possible leverage of available capacity, optimal country volume allocation.

In cooperation with STO develops & implements short/midterm identifies and implements measures to improve COGS. Reviews and proposes cost roadmap improvement to ensures profitably level in the commercial units.

Financial pre-launch reviews to assess target product profile planning, COGS position, supply & forecast scenarios including supporting global decision on country launches and global view of launch forecasts.

Leads the Generics financial performance monitoring (Monthly Reporting, Last Estimates) as well as supporting high level target setting process (Budget & Strat. Plan). Assesses financial implications of the pipeline value.

Co-leads the medium- and long-term volume and value projections in alignment with Regions, countries and STO.

Acts as a trusted Generics finance partner to STO, CCO, Development, Global Finance, and Regional leadership-ensuring cross-functional alignment and enabling high-quality, integrated decision-making at the enterprise level. Acts as platform generics business partner for the Finance…